Evotec Se (EVO) — SEC Filings
Latest SEC filings for Evotec Se. Recent 6-K filing on Apr 24, 2026. AI-decoded analysis of earnings, risk factors, and insider trades.
Overview
Evotec Se (EVO) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 6-K filed on Apr 24, 2026: Evotec SE filed a Form 6-K on April 24, 2026, reporting information as a foreign issuer. The filing includes the main 6-K document and exhibits, with the company's mailing and business addresses listed as ESSENER BOGEN 7, HAMBURG, Germany. The filing is related to its operations in the pharmaceutica
Sentiment Summary
Across 4 filings, the sentiment breakdown is: 4 neutral. The dominant filing sentiment for Evotec Se is neutral.
Filing Type Overview
Evotec Se (EVO) has filed 3 6-K, 1 20-F with the SEC between Apr 2026.
Recent Filings (4)
-
Evotec SE Files 6-K Report
— 6-K · Apr 24, 2026 Risk: low
Evotec SE filed a Form 6-K on April 24, 2026, reporting information as a foreign issuer. The filing includes the main 6-K document and exhibits, with the compan -
Evotec SE Files 6-K Report on April 8, 2026
— 6-K · Apr 8, 2026 Risk: low
Evotec SE filed a Form 6-K on April 8, 2026, reporting information as a foreign issuer. The filing includes various documents, such as the main 6-K form and exh -
Evotec SE Files 2025 Annual Report (20-F)
— 20-F · Apr 8, 2026 Risk: medium
Evotec SE filed its 20-F annual report on April 8, 2026, for the fiscal year ending December 31, 2025. The filing includes various exhibits such as the main 20- - 6-K Filing — 6-K · Apr 7, 2026
Risk Profile
Risk Assessment: Of EVO's 3 recent filings, 0 were flagged as high-risk, 1 as medium-risk, and 2 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.
Top Tags
foreign-issuer (2) · regulatory-filing (1) · pharmaceuticals (1) · filing (1) · corporate-update (1) · annual-report (1) · 20-F (1) · financials (1)
Key Numbers
- 6-K Document Size: 9933 — Indicates the size of the primary filing document in KB.
- EX-99.1 Document Size: 17002 — Indicates the size of Exhibit 99.1 in KB.
- SEC Accession Number: 0001104659-26-040768 — Unique identifier for the filing
- iXBRL 20-F size: 7660104 — Size of the main interactive data document
- Number of Documents: 46 — Total documents included in the filing
Frequently Asked Questions
What are the latest SEC filings for Evotec Se (EVO)?
Evotec Se has 4 recent SEC filings from Apr 2026, including 3 6-K, 1 20-F. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of EVO filings?
Across 4 filings, the sentiment breakdown is: 4 neutral. The dominant sentiment is neutral.
Where can I find Evotec Se SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Evotec Se (EVO) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Evotec Se?
Financial highlights for Evotec Se are available when 10-K or 10-Q filings are enriched with AI analysis. Check back as new filings are processed.
What is the investment thesis for EVO?
Investment thesis data for EVO will be available once enriched filings are processed.
Who are the key executives at Evotec Se?
Executive information for Evotec Se is extracted from SEC filings as they are enriched with AI analysis.
What are the main risk factors for Evotec Se stock?
Of EVO's 3 assessed filings, 0 were flagged high-risk, 1 medium-risk, and 2 low-risk.
What are recent predictions and forward guidance from Evotec Se?
Forward guidance and predictions for Evotec Se are extracted from SEC filings as they are enriched.